Endonovo Therapeutics... Unlike the other companies

New Post Public Reply Private Reply Replies (0) Message Board
CyberC
351
Endonovo Therapeutics...

Unlike the other companies discussed in this article, Endonovo Therapeutics (OTCQB:ENDV) takes a totally different approach to creating liver disease therapies. This company focuses on developing non-implantable and non-invasive bioelectronic devices and therapies. These devices build upon Time-Varying Electromagnetic Field (TVEMF) technology originally developed at NASA that uses electromagnetic pulses to deliver electrical stimulation to the nervous system, tissues and organs to reduce inflammation and cell death.

The company's lead product, Immunotronics, makes use of a non-invasive immuno-regulatory device for preventing and treating vital organ failure through the reduction of inflammation and cell death. The technology was identified in pre-clinical studies to be a novel non-pharmacological method of treating acute inflammation. Currently, Endonovo's Immunotronics platform is geared towards targeting acute inflammation in vital organs and in particular the liver, which appears to hold the most potential in proving efficacy of the device as well as generating returns.

There are a number of reasons why Endonovo could prove to be a game changer in the liver treatment space once its bioelectronic device gets approved by the FDA as a medical device. For starters, the company won't spend as much money and time in clinical trials compared to new drugs, meaning it can be brought to market much faster.

Also, these devices could ultimately prove to be the best solution for liver disease treatments since they don't expose patients to any risk of drug induced liver injury. Conservatively, even if Endonovo's devices manage to capture just 1 percent of the total liver treatments in the U.S., the company's $50 million valuation will more than double. Furthermore, unlike other treatments for liver diseases, which target narrow physiologic and pathologic processes, Endonovo's technology broadly targets inflammation and excessive cell death, which are believed to be the principal drivers of vital organ failure.

This means if Endonovo proves its technology reduces inflammation in the liver and treat/prevent liver failure, then the possibility exists it can replicate those results in other organs like the kidneys or heart as well. As such, this would imply its current share price of under $1 doesn't reflect the massive opportunity presented by the company. Essentially, Endonovo is part of the liver disease space, although not solely a liver disease company.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Editor's Note: This article covers one or more stocks trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.

https://seekingalpha.com/article/3968546-4-st...treatments

Endonovo Therapeutics, Inc. (ENDV) Stock Research Links

ENDV Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Net Zero Efforts to Cost Europe €60B Annually by 2050

Updated Category News Views 91

Hefty Prices Loom Over Net Zero Commitments Well, strap in for a wallet buster, folks. Europe's largest players are staring down the barrel of a colossal €60 billion annual bill to clean up their carbon mess by 2050. That's the ticker in Senken's latest report, 'Pace of Change 2026.' Talks like these remind me there's no such thing as a free lunch, especially when...

Continue Reading
DemandTec Leads the Pack in Retail Pricing Arena

Updated Category News Views 26

DemandTec's Climb to Retail Pricing Stardom The news hitting the streets is that DemandTec's carved out a top spot in QKS Group's SPARK Matrix™ for Intelligent Retail Pricing & Promotion Optimization for 2026. In an industry filled with slick operators and gimmicks, it takes some real chops to stand out. They've clinched this position by rolling out a platform that ties...

Continue Reading
Roche Delivers Endotrophin Assay to Nordic Bioscience Lab

Updated Category News Views 43

Roche Opens New Frontier in Diagnostic Biomarkers Get ready to chew on this: Roche Diagnostics is bringing something new to Nordic Bioscience's CLIA lab. They're offering up their Endotrophin research prototype assay on the cobas® e801 Analyzer. Now, what does this mean for the scientific world? Well, it might just shake things up for those battling cardiovascular and...

Continue Reading
Phoenix Contact Achieves Guinness Record in Wiring

Updated Category News Views 160

A Blitz of Wires and Innovation Boy, did Phoenix Contact shake things up in Blomberg. On a crisp November day, a group of fresh-faced first-year students pulled off something astounding—wiring 500 terminal blocks in a jaw-dropping 2 minutes and 20 seconds. This wasn’t just any effort; it was enough to earn them a shiny new Guinness World Record. What they did wasn’t...

Continue Reading
DoGo Power Revamps Energy for Remote Indonesian Isle

Updated Category News Views 77

Bringing Light to Pagerungan Kecil Island These days, if you wander into the fishing communities of Pagerungan Kecil Island, the buzz isn't just from the daily catch. Residents are talking about power, and not the kind you get from a generator spluttering along—I'm talking about a brand-new energy storage system that’s turning the lights on in ways these folks have...

Continue Reading
Evotec’s $2.9M Grant Advances Drug Safety Tech

Updated Category News Views 101

Revitalizing Drug Development with Human Stem Cells Evotec's latest win—a crisp $2.9 million grant from the Gates Foundation—is like a shot of adrenaline for drug safety innovation. This isn't just another drop in the bucket; it's a solid boost toward improving how we screen potential drugs for fetal risks before they're tossed into the costly whirlpool of clinical...

Continue Reading
Medtronic's Bold Move to Own Carotid Market Full-Scale

Updated Category News Views 44

When a giant like Medtronic makes a move, you can bet investors take notice, and this latest acquisition is no exception. They’re reaching into their deep pockets to acquire Contego Medical, a company shaking up the world of carotid artery disease treatments. It’s a tactical strike to solidify their leadership in cardiovascular solutions. Medtronic's Bet on Innovation...

Continue Reading
ROBOTERA Debuts XHAND 1 Pro-U in NVIDIA Demo

Updated Category News Views 20

ROBOTERA Steps Up with XHAND 1 Pro-U Move over, traditional robotics; ROBOTERA is here to shake things up with their latest marvel, the XHAND 1 Pro-U. This futuristic gadget isn't just making waves at the Conference on Robot Learning (CoRL) where Jim Fan of NVIDIA spotlighted it in his GR00T 2 demo, it's setting a new bar for robotic dexterity. Hand in Glove with Human...

Continue Reading
Atomera Preps for Key Craig-Hallum Conference

Updated Category News Views 13

Unpacking the NYC Gathering Alight, let's comb through the moving parts here. Atomera Inc., ticker NASDAQ: ATOM for those eyeing the dance of numbers, is all set to step into the limelight at the 17th Annual Craig-Hallum Alpha Select Conference on November 17, 2026. This shindig isn't just another date on the calendar; it's a strategic haunt where Atomera will rub...

Continue Reading
ICCSD in Beijing: AI and Culture's Future Explored

Updated Category News Views 114

AI's Intersection with Culture in the Spotlight Imagine a room full of people hammering out the future of AI and culture—it starts to feel like a melting pot for the mind. That was the scene in Beijing when the ICCSD Advisory Committee congregated on October 26, 2026. With experts pooling from four different countries, there was no shortage of fireworks. They hashed out...

Continue Reading

Top 5 Most Recently Viewed Articles

CSX Corporation Teams Up for Q1 Earnings Conference Call

Updated Category News Views 131

CSX Corporation's Upcoming First Quarter Earnings Release CSX Corporation (NASDAQ: CSX) is excited to announce its first-quarter earnings release slated for a date following the market close. This pivotal moment will take place on a Wednesday, with management inviting participants to join their insightful conference call. Details of the Earnings Call A live webcast and...

Continue Reading
Innovative ReWalk 7 Exoskeleton Now Available for All Users

Updated Category News Views 345

The Launch of ReWalk 7 Personal Exoskeleton Lifeward Ltd., known for its groundbreaking innovations in medical technology, has recently unveiled its seventh generation of personal exoskeletons, the ReWalk 7. This next-generation device is now available throughout the United States, primarily aiming to benefit individuals with spinal cord injuries (SCI). This remarkable...

Continue Reading
Eve's Certification Progress Marks Aviation Milestone

Updated Category News Views 51

Certification: A New Lease on Air Mobility Folks, the air mobility future is taking one giant leap forward, and Eve Air Mobility is right at the helm. With Brazil’s aviation authority spearheading a consultation for updated airworthiness criteria and Eve stepping up for European certification, these advancements aren't just footnotes—they're headlines. NYSE:EVEX has...

Continue Reading
Exciting Launch of Lofthill Residences: A Premier Investment Hub

Updated Category News Views 164

Lofthill Residences: A Fresh Investment Opportunity in Kuala Lumpur The real estate market in Kuala Lumpur has taken an exciting turn with the introduction of Lofthill Residences, a groundbreaking initiative by TRE Towers and the Armani Group. Conveniently located near the vibrant KLCC and just a short walk from the Raja Uda MRT station, this development stands out as a...

Continue Reading
Exclaimer Welcomes Rob Singer as CEO to Propel Growth

Updated Category News Views 385

Exclaimer Welcomes New Leadership for Future Growth Exclaimer, a leader in email signature management, has announced the appointment of Rob Singer as its new CEO. This comes at a key moment for the company, which has recently doubled its annual revenue and is set to expand its presence with new offices opening soon. Experience and Vision Matter Rob Singer comes to...

Continue Reading